Direct Enhancement Effect of Hippocampal Cholinergic Neurostimulating Peptide on Cholinergic Activity in the Hippocampus
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24108916 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yuta Madokoro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. Hauptthemen laut MEDLINE: Nerve Growth Factor, Neuropeptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Nagoya City University, Japan Society for the Promotion of Science, Nagoya City University.
Abstract (Originalsprache)
The cholinergic efferent network from the medial septal nucleus to the hippocampus is crucial for learning and memory. This study aimed to clarify whether hippocampal cholinergic neurostimulating peptide (HCNP) has a rescue function in the cholinergic dysfunction of HCNP precursor protein (HCNP-pp) conditional knockout (cKO). Chemically synthesized HCNP or a vehicle were continuously administered into the cerebral ventricle of HCNP-pp cKO mice and littermate floxed (control) mice for two weeks via osmotic pumps. We immunohistochemically measured the cholinergic axon volume in the stratum oriens and functionally evaluated the local field potential in the CA1. Furthermore, choline acetyltransferase (ChAT) and nerve growth factor (NGF) receptor (TrkA and p75NTR) abundances were quantified in wild-type (WT) mice administered HCNP or the vehicle. As a result, HCNP administration morphologically increased the cholinergic axonal volume and electrophysiological theta power in HCNP-pp cKO and control mice. Following the administration of HCNP to WT mice, TrkA and p75NTR levels also decreased significantly. These data suggest that extrinsic HCNP may compensate for the reduced cholinergic axonal volume and theta power in HCNP-pp cKO mice. HCNP may function complementarily to NGF in the cholinergic network in vivo. HCNP may represent a therapeutic candidate for neurological diseases with cholinergic dysfunction, e.g., Alzheimer’s disease and Lewy body dementia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
ORCID-Profile: Masayuki Mizuno
Förderung
- Grant-in-Aid for Nagoya City University
- Japan Society for the Promotion of Science
- Nagoya City University
- The Hori Sciences and Arts Foundation
- The Nitto Foundation
Zitieren
APA
Madokoro, Y., Kato, D., Tsuda, Y., Arakawa, I., Suzuki, K., Sato, T., Mizuno, M., Uchida, Y., Ojika, K., & Matsukawa, N. (2023). Direct Enhancement Effect of Hippocampal Cholinergic Neurostimulating Peptide on Cholinergic Activity in the Hippocampus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108916
Vancouver
Madokoro Y, Kato D, Tsuda Y, Arakawa I, Suzuki K, Sato T, et al. Direct Enhancement Effect of Hippocampal Cholinergic Neurostimulating Peptide on Cholinergic Activity in the Hippocampus. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108916
BibTeX
@article{Madokoro2023,
author = {Madokoro, Yuta and Kato, Daisuke and Tsuda, Yo and Arakawa, Itsumi and Suzuki, Kengo and Sato, Toyohiro and Mizuno, Masayuki and Uchida, Yuto and Ojika, Kosei and Matsukawa, Noriyuki},
title = {Direct Enhancement Effect of Hippocampal Cholinergic Neurostimulating Peptide on Cholinergic Activity in the Hippocampus},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24108916}
}
EUVIMED